LIFECODES Single Antigen Assays | Antibody Testing Portfolio

Optimized Performance, Increased Coverage.

The new, enhanced LSA Assays deliver increased coverage, optimized performance, and improve the overall workflow of the LIFECODES® HLA Antibody Analysis portfolio.

Let's Get Started

LIFECODES^® Single Antigen Assays (LSA) Benefits

Clear
Results

High
Efficiency

Optimized
Performance

The Details

We strive to develop assays to increase your ability to find acceptable donors and provide new beginnings for more transplant patients. The Enhanced LSA Assays deliver increased coverage, optimized performance, and improve the overall workflow of the LIFECODES^® HLA Antibody Analysis portfolio.

Improved Performance

More comprehensively determine the sample’s antibody profile with expanded antigen panels
Result in fewer false positive reactions by reducing non-specific reactivity

Increased Accuracy

Greater lot to lot reproducibility with all antigen values normalized to an external standard
Reduce inter and intra site variability with a new calculation for positive/negative assignments

Product offerings may differ by region, please check with your local Werfen representative for regulatory status in your area.

LIFECODES^® Single Antigen Assays (LSA) Downloads

Resource Library

PACKAGE INSERTS (PI/ IFU), SAFETY DATA SHEETS (SDS), CERTIFICATES of ANALYSIS, LOT SPECIFIC FILES, and more can be accessed on our customer center.

Our Certifications

View All Certifications

Experience Our Virtual Lab

Contact your sales representative for a personal tour.

Related Products

Testimonial
Transplant
Customer

I really appreciate Immucor's continuous interest in listening to the customer. That is what makes Immucor a great partner to our labs. I know that our needs and ideas will be heard and taken into consideration to improve the products. That makes a world of difference to us in the labs and is truly appreciated.

Valia Bravo-Egana, PhD, F(ACHI), MBA, Director, Technical Supervisor and Clinical Consultant, Histocompatibility/Immunology Laboratory, Medical College of Georgia, USA

Let's Get Started On Your Story

Testimonial
Transplant
Customer

The fact that Immucor representatives are former transplant technologists adds one more layer of support for us. I appreciate Immucor's commitment to comprehensive customer support, from assay and software development to technical and educational support. It's a team approach between vendor and customer that is more than a business relationship. It's a joint mission to benefit patients.

Ellen Klohe, PhD, D(ABHI), HLA Laboratory Director, Vitalant Spokane Laboratory, USA

Let's Get Started On Your Story

Testimonial
Transplant
Customer

Immucor products enable us to accurately assign HLA antibody specificities for better transplant outcomes!

Sam Ho, PhD, D(ABHI), FAACC, HLA Lab Director, Gift of Hope Organ & Tissue Donor Network, USA

Let's Get Started On Your Story

Testimonial
Transplant
Customer

Valia Bravo-Egana, PhD, F(ACHI), MBA, Director, Technical Supervisor and Clinical Consultant, Histocompatibility/Immunology Laboratory, Medical College of Georgia, USA

Let's Get Started On Your Story

Testimonial
Transplant
Customer

Ellen Klohe, PhD, D(ABHI), HLA Laboratory Director, Vitalant Spokane Laboratory, USA

Let's Get Started On Your Story

Testimonial
Transplant
Customer

Immucor products enable us to accurately assign HLA antibody specificities for better transplant outcomes!

Sam Ho, PhD, D(ABHI), FAACC, HLA Lab Director, Gift of Hope Organ & Tissue Donor Network, USA

Let's Get Started On Your Story

Testimonial
Transplant
Customer

Valia Bravo-Egana, PhD, F(ACHI), MBA, Director, Technical Supervisor and Clinical Consultant, Histocompatibility/Immunology Laboratory, Medical College of Georgia, USA

Let's Get Started On Your Story

Upcoming Events,
Webinars & Workshops

View Events Calendar

Keep Up With Us

View All News & Blogs

News & Blogs

Werfen acquires Omixon

Werfen has completed the acquisition of Omixon, a privately held company based in Budapest, Hungary, focused on the development and commercialization of Next Generation Sequencing (NGS) technologies in transplant diagnostics. The acquisition expands Werfen’s portfolio of transplant diagnostics solutions for...

Continue Reading View All